Ftorafur therapy in acute pancreatitis

Area of Science:

• Gastroenterology
• Oncology
• Pharmacology

Background:

• Acute pancreatitis is a serious inflammatory condition.
• Current treatments for acute pancreatitis have limitations.
• Ftorafur is a chemotherapy agent with potential anti-inflammatory properties.

Purpose of the Study:

• To evaluate the efficacy of Ftorafur in treating acute pancreatitis.
• To assess the impact of Ftorafur on key biochemical markers of pancreatitis.

Main Methods:

• A clinical study involving patients with acute pancreatitis.
• Administration of daily Ftorafur dosage (200 mg).
• Monitoring of serum and urine amylase levels and white blood cell (WBC) counts.

Main Results:

• Significant decrease in urine amylase levels within three days of Ftorafur treatment.
• No significant changes in serum amylase or WBC counts in the Ftorafur group compared to the control group.
• Earlier normalization of serum and urine amylase levels observed in the Ftorafur group.

Conclusions:

• Ftorafur demonstrates potential as an effective treatment for acute pancreatitis.
• Ftorafur may lead to reduced treatment duration and costs.
• The drug exhibits cytoprotective effects on the pancreas through protein synthesis inhibition.